Our news

MITEM PHARMA ACQUIRES WORLDWIDE RIGHTS TO DESFERAL®

Press Release, 25th of September 2024

MITEM PHARMA acquires worldwide rights to DESFERAL® (deferoxamine) with the backing of TECHLIFE CAPITAL and MACSF.